If the U.K. leaves the EU with no deal, it could be “catastrophic” for medicine supplies — and necessitate emergency powers, the pharmaceuticals industry says.
As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers.
The term “forensic science” conjures up images of police dramas and crime investigations. But it turns out to have a strong connection to global supply chains, too.
The sky isn’t falling. That’s the message coming from Corporate America after President Trump reached a deal to revise the North American Free Trade Agreement.
There’s a lot to digest in the new trade agreement that the United States, Mexico and Canada finalized in deadline-beating fashion on Sunday, starting with a name change.